Billionaire Profile
Wolfgang Leitner
Global Rank
#1313

Image: Public domain | via Wikimedia Commons

Wolfgang Leitner

CEO, Andritz AG
AT
Real-Time Net Worth
$3B
As of December 2025
Age
72
Source
Engineering
Industry
construction-engineering
Citizenship
AT

Biography

Wolfgang Leitner, born in 1953, is an Austrian billionaire renowned for his significant contributions to the engineering and construction industry. As the former CEO of Andritz AG, he transformed the company into a global leader, showcasing exceptional leadership and business acumen. His career includes a strong foundation in chemistry, holding a doctorate from the University of Graz. Leitner's estimated net worth is $3.0 billion, a testament to his successful career in engineering. Leitner's career is also marked by his founding of Genericon Pharma, highlighting his entrepreneurial spirit and business versatility. His dedication to excellence and innovation has solidified his legacy in the business world. Leitner is married and has two children.

Wealth Over Time

In-Depth Profile

Early Life and Education

Wolfgang Leitner was born on March 27, 1953, in Graz, Austria. His father was a metal worker at Andritz AG. Leitner's early life was marked by a strong interest in science and engineering. He excelled in his studies, which led him to pursue higher education in chemistry. In 1978, he earned a doctorate in chemistry from the University of Graz.

Rise to Success

After completing his education, Leitner began his career in research at Vianova, an Austrian subsidiary of Hoechst AG. In 1981, he joined McKinsey & Company as a management consultant. A pivotal moment in his career came in 1987 when he joined Andritz AG as the CFO. He became CEO in 1994, a role he held until 2022. Under Leitner's leadership, Andritz AG experienced remarkable growth, becoming a global leader in the pulp and paper industry. He oversaw the company's expansion into new markets, including renewable energy. In 1999, Leitner acquired a 26% stake in Andritz AG. He led a management buyout with private equity firms and took the company public on the Vienna Stock Exchange in 2001.

Key Business Strategies

Leitner's success at Andritz AG was built on strategic acquisitions and a focus on innovation. He spearheaded the company's expansion through over 70 acquisitions. Leitner's commitment to research and development enabled Andritz to stay at the forefront of the industry. Furthermore, he invested in emerging markets, particularly in Asia and Latin America. Leitner also founded Genericon Pharma in 1986, demonstrating his entrepreneurial drive.

Philanthropy

While specific philanthropy amounts are not readily available, Leitner is known for his interest in sustainable forestry, investing in forestry initiatives. He has also shown interest in dairy farming in New Zealand.

Career Milestones

1978

Doctorate in Chemistry

Obtained a doctorate in chemistry from the University of Graz, Austria.

1981

Management Consultant

Joined McKinsey & Company as a management consultant.

1987

CFO of Andritz AG

Joined Andritz AG as Chief Financial Officer.

1994

CEO of Andritz AG

Became CEO of Andritz AG.

1999

Acquired a 26% Stake

Acquired a 26% stake in Andritz AG.

2022

Deputy Chairman of the Supervisory Board of Andritz AG

Became Deputy Chairman of the Supervisory Board of Andritz AG.

Philanthropy & Social Impact

Environmental

Forestry Investments

Undisclosed

Investing in forestry initiatives in New Zealand and Europe.

Business Philosophy & Leadership

Notable Quotes

"I wonder why politicans don't show any interest in supporting businesses and keeping them in the country."